Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.
2.

Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events.

Arca M, Gaspardone A.

Drugs. 2007;67 Suppl 1:29-42. Review.

PMID:
17910519
3.

Atorvastatin: its clinical role in cerebrovascular prevention.

Gaspardone A, Arca M.

Drugs. 2007;67 Suppl 1:55-62. Review.

PMID:
17910521
5.
6.

Managing dyslipidemia in the high-risk patient.

Stein EA.

Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.

PMID:
11900720
7.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
8.

Cholesterol and atherosclerosis: a contemporary perspective.

Kashyap ML.

Ann Acad Med Singapore. 1997 Jul;26(4):517-23. Review.

PMID:
9395824
9.

Expanding roles for atorvastatin.

Singh V, Deedwania P.

Drugs Today (Barc). 2008 Jun;44(6):455-71. doi: 10.1358/dot.2008.44.6.1217468. Review.

PMID:
18596999
10.

Interpretation of the evidence for the efficacy and safety of statin therapy.

Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R.

Lancet. 2016 Nov 19;388(10059):2532-2561. doi: 10.1016/S0140-6736(16)31357-5. Epub 2016 Sep 8. Review.

PMID:
27616593
11.

An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.

Ansell BJ, Watson KE, Fogelman AM.

JAMA. 1999 Dec 1;282(21):2051-7. Review.

PMID:
10591388
12.
13.

[Statins and unstable angina: MIRACL].

Puel J.

Ann Endocrinol (Paris). 2001 Feb;62(1 Pt 2):145-8. Review. French.

PMID:
11240417
15.

LDL, HDL, VLDL, and CVD Prevention: Lessons from Genetics?

Hewing B, Landmesser U.

Curr Cardiol Rep. 2015 Jul;17(7):610. doi: 10.1007/s11886-015-0610-z. Review.

PMID:
26031673
16.

Measurement and management of hyperlipidemia for the primary prevention of coronary heart disease.

Froom J, Froom P, Benjamin M, Benjamin BJ.

J Am Board Fam Pract. 1998 Jan-Feb;11(1):12-22. Review.

PMID:
9456442
17.

Method of LDL cholesterol measurement influences classification of LDL cholesterol treatment goals: clinical research study.

Agrawal M, Spencer HJ, Faas FH.

J Investig Med. 2010 Dec;58(8):945-9. doi: 10.231/JIM.0b013e3181fb7ca7. Review.

18.
19.
20.

Reduction in coronary heart disease: clinical and anatomical considerations.

Satler LF, Pearle DL, Rackley CE.

Clin Cardiol. 1989 Aug;12(8):422-6. Review.

Supplemental Content

Support Center